1,2-dimethylhydrazine decreases expression ISO RGD:1332511 6480464 1, 2-Dimethylhydrazine results in decreased expression of SYBU mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1604347 6480464 Estradiol results in decreased expression of SYBU mRNA CTD PMID:19619570 17beta-estradiol increases expression ISO RGD:1604347 6480464 Estradiol results in increased expression of SYBU mRNA CTD PMID:24758408 more ... 17beta-estradiol multiple interactions ISO RGD:1604347 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SYBU mRNA more ... CTD PMID:17404688 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1604347 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SYBU mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332511 6480464 Tetrachlorodibenzodioxin affects the expression of SYBU mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SYBU mRNA CTD PMID:26232522 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1604347 6480464 Tetrachlorodibenzodioxin affects the expression of SYBU mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1604347 6480464 Tetrachlorodibenzodioxin results in decreased expression of SYBU mRNA CTD PMID:19619570 , PMID:20106945 2-methylcholine affects expression ISO RGD:1604347 6480464 beta-methylcholine affects the expression of SYBU mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1332511 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SYBU mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol decreases expression ISO RGD:1604347 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of SYBU mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SYBU mRNA CTD PMID:36041667 acrylamide decreases expression ISO RGD:1332511 6480464 Acrylamide results in decreased expression of SYBU mRNA CTD PMID:30807115 aflatoxin B1 decreases methylation ISO RGD:1604347 6480464 Aflatoxin B1 results in decreased methylation of SYBU gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:1604347 6480464 Tretinoin results in decreased expression of SYBU mRNA CTD PMID:23724009 antirheumatic drug increases expression ISO RGD:1604347 6480464 Antirheumatic Agents results in increased expression of SYBU mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1604347 6480464 Arsenic affects the methylation of SYBU gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1604347 6480464 Arsenic affects the methylation of SYBU gene CTD PMID:25304211 atrazine increases expression ISO RGD:1604347 6480464 Atrazine results in increased expression of SYBU mRNA CTD PMID:22378314 avobenzone decreases expression ISO RGD:1604347 6480464 avobenzone results in decreased expression of SYBU mRNA CTD PMID:31016361 benzo[a]pyrene affects methylation ISO RGD:1604347 6480464 Benzo(a)pyrene affects the methylation of SYBU 5' UTR, Benzo(a)pyrene affects the methylation of SYBU exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1604347 6480464 Benzo(a)pyrene results in decreased expression of SYBU mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1604347 6480464 Benzo(a)pyrene results in increased methylation of SYBU 3' UTR CTD PMID:27901495 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SYBU mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1332511 6480464 bisphenol A results in decreased expression of SYBU mRNA CTD PMID:32156529 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SYBU mRNA CTD PMID:36041667 bisphenol A multiple interactions ISO RGD:1604347 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SYBU gene CTD PMID:31601247 bisphenol A increases methylation ISO RGD:1604347 6480464 bisphenol A results in increased methylation of SYBU gene CTD PMID:31601247 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SYBU mRNA CTD PMID:36041667 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of SYBU mRNA CTD PMID:19167457 calcitriol decreases expression ISO RGD:1604347 6480464 Calcitriol results in decreased expression of SYBU mRNA CTD PMID:16002434 carbon nanotube increases expression ISO RGD:1332511 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1332511 6480464 Nanotubes, Carbon results in decreased expression of SYBU mRNA CTD PMID:25554681 cisplatin affects response to substance ISO RGD:1604347 6480464 SYBU protein affects the susceptibility to Cisplatin CTD PMID:16217747 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of SYBU mRNA CTD PMID:17898221 copper(II) sulfate increases expression ISO RGD:1604347 6480464 Copper Sulfate results in increased expression of SYBU mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1604347 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SYBU mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1604347 6480464 Cyclosporine results in decreased expression of SYBU mRNA CTD PMID:20106945 deoxynivalenol decreases expression ISO RGD:1604347 6480464 deoxynivalenol results in decreased expression of SYBU mRNA CTD PMID:31863870 dichloroacetic acid increases expression ISO RGD:1332511 6480464 Dichloroacetic Acid results in increased expression of SYBU mRNA CTD PMID:28962523 dioxygen decreases expression ISO RGD:1604347 6480464 Oxygen deficiency results in decreased expression of SYBU mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:1332511 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYBU mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1604347 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SYBU mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:1332511 6480464 Ethanol affects the splicing of SYBU mRNA CTD PMID:30319688 formaldehyde decreases expression ISO RGD:1604347 6480464 Formaldehyde results in decreased expression of SYBU mRNA CTD PMID:20655997 formaldehyde increases expression ISO RGD:1604347 6480464 Formaldehyde results in increased expression of SYBU mRNA CTD PMID:27664576 fulvestrant multiple interactions ISO RGD:1604347 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SYBU gene CTD PMID:31601247 gallic acid decreases expression ISO RGD:1604347 6480464 Gallic Acid results in decreased expression of SYBU mRNA CTD PMID:34408198 hydrogen peroxide affects expression ISO RGD:1604347 6480464 Hydrogen Peroxide affects the expression of SYBU mRNA CTD PMID:20044591 hydroquinone increases expression ISO RGD:1604347 6480464 hydroquinone results in increased expression of SYBU mRNA CTD PMID:31256213 lead(0) affects expression ISO RGD:1604347 6480464 Lead affects the expression of SYBU mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1604347 6480464 Lead affects the expression of SYBU mRNA CTD PMID:28903495 mercury dibromide increases expression ISO RGD:1604347 6480464 mercuric bromide results in increased expression of SYBU mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1604347 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA CTD PMID:27188386 methylmercury chloride decreases expression ISO RGD:1604347 6480464 methylmercuric chloride results in decreased expression of SYBU mRNA CTD PMID:28001369 mitomycin C affects response to substance ISO RGD:1604347 6480464 SYBU protein affects the susceptibility to Mitomycin CTD PMID:16217747 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of SYBU gene CTD PMID:33148267 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1332511 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SYBU mRNA] CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1332511 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SYBU mRNA CTD PMID:25566086 N-nitrosodiethylamine decreases expression ISO RGD:1604347 6480464 Diethylnitrosamine results in decreased expression of SYBU mRNA CTD PMID:21527772 N-nitrosodiethylamine increases expression ISO RGD:1332511 6480464 Diethylnitrosamine results in increased expression of SYBU mRNA CTD PMID:24535843 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SYBU mRNA CTD PMID:32680482 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of SYBU gene CTD PMID:33148267 phenylmercury acetate increases expression ISO RGD:1604347 6480464 Phenylmercuric Acetate results in increased expression of SYBU mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1604347 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1332511 6480464 pirinixic acid results in increased expression of SYBU mRNA CTD PMID:20813756 pirinixic acid multiple interactions ISO RGD:1604347 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SYBU mRNA CTD PMID:19710929 progesterone multiple interactions ISO RGD:1604347 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SYBU mRNA, [Progesterone co-treated with Estradiol] results in increased expression of SYBU mRNA CTD PMID:17404688 , PMID:20660070 progesterone decreases expression ISO RGD:1604347 6480464 Progesterone results in decreased expression of SYBU mRNA CTD PMID:21540246 progesterone increases expression ISO RGD:1604347 6480464 Progesterone results in increased expression of SYBU mRNA CTD PMID:17404688 quercetin decreases expression ISO RGD:1604347 6480464 Quercetin results in decreased expression of SYBU mRNA CTD PMID:21632981 raloxifene multiple interactions ISO RGD:1604347 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of SYBU mRNA, [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of SYBU mRNA CTD PMID:19059307 resveratrol multiple interactions ISO RGD:1604347 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SYBU mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:1604347 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1604347 6480464 Silicon Dioxide results in decreased expression of SYBU mRNA CTD PMID:25351596 sodium arsenite decreases expression ISO RGD:1604347 6480464 sodium arsenite results in decreased expression of SYBU mRNA CTD PMID:28595984 , PMID:34032870 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of SYBU mRNA CTD PMID:25993096 Soman decreases expression EXP 6480464 Soman results in decreased expression of SYBU mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1604347 6480464 Sunitinib results in increased expression of SYBU mRNA CTD PMID:31533062 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of SYBU mRNA CTD PMID:26141394 T-2 toxin decreases expression ISO RGD:1604347 6480464 T-2 Toxin results in decreased expression of SYBU mRNA CTD PMID:31863870 tamoxifen multiple interactions ISO RGD:1604347 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of SYBU mRNA, [Tamoxifen co-treated with ESR2 protein] results in decreased expression of SYBU mRNA CTD PMID:19059307 testosterone multiple interactions ISO RGD:1332511 6480464 1 more ... CTD PMID:33848595 testosterone decreases expression ISO RGD:1332511 6480464 Testosterone deficiency results in decreased expression of SYBU mRNA CTD PMID:33848595 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SYBU mRNA CTD PMID:34492290 tributylstannane decreases expression ISO RGD:1332511 6480464 tributyltin results in decreased expression of SYBU mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SYBU mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1604347 6480464 trichostatin A results in increased expression of SYBU mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1604347 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA CTD PMID:27188386 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of SYBU mRNA CTD PMID:30589522 triptonide decreases expression ISO RGD:1332511 6480464 triptonide results in decreased expression of SYBU mRNA CTD PMID:33045310 urethane increases expression ISO RGD:1604347 6480464 Urethane results in increased expression of SYBU mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1332511 6480464 Valproic Acid affects the expression of SYBU mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1604347 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1604347 6480464 Valproic Acid affects the expression of SYBU mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1604347 6480464 Valproic Acid results in increased expression of SYBU mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:1604347 6480464 Valproic Acid results in decreased methylation of SYBU gene CTD PMID:29154799 zoledronic acid decreases expression ISO RGD:1604347 6480464 Zoledronic Acid results in decreased expression of SYBU mRNA CTD PMID:24714768